TEVA Teva Pharma Industries Ltd ADR

$18.48

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Teva Pharma Industries Ltd ADR

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs, and biopharmaceuticals in North America, Europe, and internationally. The company is headquartered in Petach Tikva, Israel.

Website: https://www.tevapharm.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
818686
Address
5 BAZEL ST, P O B 3190, PETACH TIKVA, IL
Valuation
Market Cap
$15.66B
P/E Ratio
nan
PEG Ratio
1.29
Price to Book
2.91
Performance
EPS
$-1.45
Dividend Yield
—
Profit Margin
-9.91%
ROE
-28.30%
Technicals
50D MA
$15.65
200D MA
$17.61
52W High
$22.80
52W Low
$12.46
Fundamentals
Shares Outstanding
1B
Target Price
$22.88
Beta
0.72

TEVA EPS Estimates vs Actual

● Estimated
● Actual

TEVA News & Sentiment

Aug 21, 2025 • Zacks Commentary NEUTRAL
Can J&J Navigate Stelara, Talc Suits, Tariff & Other Headwinds?
J&J battles Stelara losses, talc lawsuits, tariffs and China headwinds while banking on growth plans and new launches to stay resilient.
Aug 21, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
REYKJAVIK, Iceland and LONDON, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited ( "Advanz Pharma" ) , a UK headquartered global ...
Aug 21, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
REYKJAVIK, ICELAND and LONDON, UK ( August 21, 2025 ) - Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited ( "Advanz Pharma" ) , a UK headquartered global ...
Aug 20, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia
REYKJAVIK, ICELAND ( August 20, 2025 ) - Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Patrik Ling has joined the company as VP Investor Relations Scandinavia, based in ...
Aug 20, 2025 • Motley Fool SOMEWHAT-BULLISH
Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters
Duquesne's billionaire boss bid adieu to Wall Street's hottest artificial intelligence (AI) stock in favor of one of the cheapest pharmaceutical stocks on the planet.
Aug 13, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
REYKJAVIK, Iceland, Aug. 13, 2025 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first six months of 2025 and ...
Sentiment Snapshot

Average Sentiment Score:

0.129
50 articles with scored sentiment

Overall Sentiment:

Neutral

TEVA Reported Earnings

Jan 29, 2025
Dec 31, 2024 (Pre market)
0.01 Surprise
  • Reported EPS: $0.71
  • Estimate: $0.70
  • Whisper: —
  • Surprise %: 1.1%
Nov 06, 2024
Sep 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.69
  • Estimate: $0.65
  • Whisper: —
  • Surprise %: 6.2%
Jul 31, 2024
Jun 30, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $0.61
  • Estimate: $0.55
  • Whisper: —
  • Surprise %: 10.9%
May 08, 2024
Mar 31, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $0.48
  • Estimate: $0.51
  • Whisper: —
  • Surprise %: -5.9%
Jan 31, 2024
Dec 31, 2023 (Pre market)
0.23 Surprise
  • Reported EPS: $1.00
  • Estimate: $0.77
  • Whisper: —
  • Surprise %: 29.9%
Nov 08, 2023
Sep 30, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.61
  • Whisper: —
  • Surprise %: -1.6%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.56
  • Estimate: $0.53
  • Whisper: —
  • Surprise %: 5.7%
May 10, 2023
Mar 31, 2023 (Pre market)
-0.16 Surprise
  • Reported EPS: $0.40
  • Estimate: $0.56
  • Whisper: —
  • Surprise %: -28.6%
Feb 08, 2023
Dec 31, 2022 (Pre market)
0.0 Surprise
  • Reported EPS: $0.71
  • Estimate: $0.71
  • Whisper: —
  • Surprise %: 0.0%

Financials